ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,403.09
0.35%
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs Yen
155.567
0.09%
Brent Oil
83.585
0.03%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) ニュース

TTNP

Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TTNP
日付受信時刻ニュースソース見出しコード企業名
2024/01/2606 : 33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2024/01/2606 : 29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
2024/01/1906 : 59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2024/01/0907 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/12/2906 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/12/2906 : 15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/11/2906 : 47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/11/1806 : 03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/11/1606 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2506 : 26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2404 : 07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/1706 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/1705 : 37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/0506 : 30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/0505 : 40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/2005 : 41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/1905 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/1820 : 30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/0906 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/3105 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/1506 : 08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0109 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0108 : 45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0108 : 44Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0108 : 42Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TTNP

最近閲覧した銘柄

NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
COIN
ETHUSD
Ethereum
FX
USDGBP
US Dollar vs Sterling
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US500
US 500
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
FX
USDEUR
US Dollar vs Euro
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有